Alagammal Perumalsamy
Papers
1
Total Citations
41
H-Index
1
About
Dr. Alagammal Perumalsamy is a developmental biologist whose pioneering work focuses on the molecular mechanisms governing early mammalian embryogenesis, particularly the role of ooplasmic factors in embryo viability. Her most cited study, "Automated Microinjection of Recombinant BCL-X into Mouse Zygotes Enhances Embryo Development" (2011, 41 citations), demonstrates a critical contribution: she showed that precisely delivering the anti-apoptotic protein BCL-X into fertilized mouse eggs significantly improves cleavage rates and blastocyst formation. This work not only identified BCL-X as a key survival factor for preimplantation development but also established an automated microinjection platform as a powerful tool for manipulating oocyte and zygote environments. By linking a specific recombinant protein to enhanced developmental progression, Perumalsamy’s research provides foundational insights for improving assisted reproductive technologies and understanding how maternal factors secure the embryo’s earliest steps. Her findings have been cited in studies on oocyte quality, embryo culture optimization, and apoptosis regulation during development, underscoring her impact on reproductive biology and translational embryology.
Research Focus
Key Achievements
Top Papers
- 1